{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:10:45Z","timestamp":1792001445434,"version":"4.4.0"},"reference-count":43,"publisher":"The Endocrine Society","issue":"3","license":[{"start":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T00:00:00Z","timestamp":1701734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Primary aldosteronism (PA) leads to kidney function deterioration after treatment, but the effects of the estimated glomerular filtration rate (eGFR) dip following adrenalectomy and its long-term implications are unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aims to examine eGFR dip in patients with unilateral PA (uPA) after adrenalectomy and clarify their long-term prognosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This multicenter prospective population-based cohort study, enrolled patients with uPA who underwent adrenalectomy. Patients were divided into 4 groups based on their eGFR dip ratio. Outcomes investigated included mortality, cardiovascular composite events, and major adverse kidney events (MAKEs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 445 enrolled patients, those with an eGFR dip ratio worse than \u221230% (n = 74, 16.6%) were older, had higher blood pressure, higher aldosterone concentration, and lower serum potassium levels. During 5.0 \u00b1 3.6 years of follow-up, 2.9% died, 14.6% had cardiovascular composite events, and 17.3% had MAKEs. The group with eGFR dip worse than \u221230% had a higher risk of MAKEs (P &amp;lt; .001), but no significant differences in mortality (P = .295) or new-onset cardiovascular composite outcomes (P = .373) were found. Multivariate analysis revealed that patients with an eGFR dip ratio worse than \u221230% were significantly associated with older age (odds ratio [OR], 1.04), preoperative eGFR (OR, 1.02), hypokalemia (OR, 0.45), preoperative systolic blood pressure (OR, 1.03), and plasma aldosterone concentration (OR, 0.99).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Within 5 years post adrenalectomy, 17.3% of patients had reduced kidney function. Notably, individuals with an eGFR dip ratio worse than \u221230% faced higher MAKE risks, underscoring the need to monitor kidney function in PA patients after surgery.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgad709","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T19:17:24Z","timestamp":1701458244000},"page":"e965-e974","source":"Crossref","is-referenced-by-count":8,"title":["Association of Dip in eGFR With Clinical Outcomes in Unilateral Primary Aldosteronism Patients After Adrenalectomy"],"prefix":"10.1210","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1376-7780","authenticated-orcid":false,"given":"Jui-Yi","family":"Chen","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Chi-Mei Medical Center , Tainan 71004 , Taiwan"},{"name":"Department of Health and Nutrition, Chia Nan University of Pharmacy and Science , Tainan 71710 , Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-How","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Urology, College of Medicine, National Taiwan University , Taipei 106319 , Taiwan"},{"name":"Department of Urology, National Taiwan University Hospital , Taipei 100225 , Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8153-1441","authenticated-orcid":false,"given":"Yen-Hung","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Taiwan University Hospital , Taipei 100225 , Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0713-4904","authenticated-orcid":false,"given":"Jeff S","family":"Chueh","sequence":"additional","affiliation":[{"name":"Department of Urology, College of Medicine, National Taiwan University , Taipei 106319 , Taiwan"},{"name":"Department of Urology, National Taiwan University Hospital , Taipei 100225 , Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsien-Yi","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Chi-Mei Medical Center , Tainan 71004 , Taiwan"},{"name":"Department of Sport Management, College of Leisure and Recreation Management, Chia Nan University of Pharmacy and Science , Tainan 71710 , Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7935-0991","authenticated-orcid":false,"given":"Vin-Cent","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Taiwan University Hospital , Taipei 100225 , Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2023,12,5]]},"reference":[{"issue":"6","key":"2024022001125568200_dgad709-B1","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1210\/er.2018-00139","article-title":"The expanding Spectrum of primary aldosteronism: implications for diagnosis, pathogenesis, and treatment","volume":"39","author":"Vaidya","year":"2018","journal-title":"Endocr Rev"},{"issue":"4","key":"2024022001125568200_dgad709-B2","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3803\/EnM.2018.33.4.429","article-title":"Primary aldosteronism and cerebrovascular diseases","volume":"33","author":"Chen","year":"2018","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"15-16","key":"2024022001125568200_dgad709-B3","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.cca.2011.02.018","article-title":"Kidney impairment in primary aldosteronism","volume":"412","author":"Wu","year":"2011","journal-title":"Clin Chim Acta"},{"issue":"6","key":"2024022001125568200_dgad709-B4","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1210\/js.2019-00019","article-title":"Adrenalectomy improves the long-term risk of End-stage renal disease and mortality of primary aldosteronism","volume":"3","author":"Chen","year":"2019","journal-title":"J Endocr Soc"},{"issue":"5","key":"2024022001125568200_dgad709-B5","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2024022001125568200_dgad709-B6","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s12020-021-02704-2","article-title":"Higher risk of chronic kidney disease and progressive kidney function impairment in primary aldosteronism than in essential hypertension. Case-control study","volume":"73","author":"Fern\u00e1ndez-Arg\u00fceso","year":"2021","journal-title":"Endocrine"},{"issue":"6","key":"2024022001125568200_dgad709-B7","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1007\/s40620-022-01267-3","article-title":"Screening for primary aldosteronism is underutilised in patients with chronic kidney disease","volume":"35","author":"Chauhan","year":"2022","journal-title":"J Nephrol"},{"issue":"6","key":"2024022001125568200_dgad709-B8","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1038\/ki.1996.265","article-title":"The hyperfiltration theory: a paradigm shift in nephrology","volume":"49","author":"Brenner","year":"1996","journal-title":"Kidney Int"},{"issue":"1 Pt 1","key":"2024022001125568200_dgad709-B9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jfma.2020.08.001","article-title":"Taiwan mini-frontier of primary aldosteronism: updating detection and diagnosis","volume":"120","author":"Chang","year":"2021","journal-title":"J Formos Med Assoc"},{"issue":"9","key":"2024022001125568200_dgad709-B10","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2024022001125568200_dgad709-B11","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/ajh.2009.89","article-title":"Primary aldosteronism: diagnostic accuracy of the losartan and captopril tests","volume":"22","author":"Wu","year":"2009","journal-title":"Am J Hypertens"},{"issue":"10","key":"2024022001125568200_dgad709-B12","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2967\/jnumed.109.064873","article-title":"131I-6beta-iodomethyl-19-norcholesterol SPECT\/CT for primary aldosteronism patients with inconclusive adrenal venous sampling and CT results","volume":"50","author":"Yen","year":"2009","journal-title":"J Nucl Med"},{"issue":"3","key":"2024022001125568200_dgad709-B13","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1177\/1470320310391329","article-title":"Verification and evaluation of aldosteronism demographics in the Taiwan Primary Aldosteronism Investigation Group (TAIPAI Group)","volume":"12","author":"Kuo","year":"2011","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"2","key":"2024022001125568200_dgad709-B14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1530\/EJE-21-0836","article-title":"Long-term mortality and cardiovascular events in patients with unilateral primary aldosteronism after targeted treatments","volume":"186","author":"Wu","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"2024022001125568200_dgad709-B15","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.jval.2020.01.024","article-title":"Nephrologist follow-up care of patients with acute kidney disease improves outcomes: taiwan experience","volume":"23","author":"Wu","year":"2020","journal-title":"Value Health"},{"issue":"10","key":"2024022001125568200_dgad709-B16","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jclinepi.2014.05.012","article-title":"Administrative data on diagnosis and mineralocorticoid receptor antagonist prescription identified patients with primary aldosteronism in Taiwan","volume":"67","author":"Wu","year":"2014","journal-title":"J Clin Epidemiol"},{"key":"2024022001125568200_dgad709-B17","doi-asserted-by":"publisher","author":"Chen","DOI":"10.6084\/m9.figshare.24428683"},{"issue":"4","key":"2024022001125568200_dgad709-B18","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/cpt.173","article-title":"Pentoxifylline decreases dialysis risk in patients with advanced chronic kidney disease","volume":"98","author":"Wu","year":"2015","journal-title":"Clin Pharmacol Ther"},{"key":"2024022001125568200_dgad709-B19","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-31245-3","volume-title":"Applied Survival Analysis Using R","author":"Moore","year":"2016"},{"issue":"4","key":"2024022001125568200_dgad709-B20","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"issue":"3","key":"2024022001125568200_dgad709-B21","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1161\/HYPERTENSIONAHA.119.13131","article-title":"Association between acute fall in estimated glomerular filtration rate after treatment for primary aldosteronism and long-term decline in renal function","volume":"74","author":"Kobayashi","year":"2019","journal-title":"Hypertension"},{"issue":"10","key":"2024022001125568200_dgad709-B22","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1007\/s11255-018-1887-9","article-title":"Change in kidney function after unilateral adrenalectomy in patients with primary aldosteronism: identification of risk factors for decreased kidney function","volume":"50","author":"Kim","year":"2018","journal-title":"Int Urol Nephrol"},{"issue":"5","key":"2024022001125568200_dgad709-B23","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1210\/jc.2013-2180","article-title":"Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease after treatment of primary aldosteronism: renal outcome of 213 cases","volume":"99","author":"Iwakura","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2024022001125568200_dgad709-B24","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1681\/ASN.2004100878","article-title":"Relative glomerular hyperfiltration in primary aldosteronism","volume":"16","author":"Ribstein","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2024022001125568200_dgad709-B25","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1053\/j.ajkd.2009.06.014","article-title":"Association of kidney function with residual hypertension after treatment of aldosterone-producing adenoma","volume":"54","author":"Wu","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"2024022001125568200_dgad709-B26","first-page":"271","article-title":"Morphologic aspects of low-potassium and low-sodium nephropathy","volume":"19","author":"Riemenschneider","year":"1983","journal-title":"Clin Nephrol"},{"issue":"11","key":"2024022001125568200_dgad709-B27","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1038\/s41591-019-0627-8","article-title":"Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease","volume":"25","author":"Lees","year":"2019","journal-title":"Nat Med"},{"issue":"9731","key":"2024022001125568200_dgad709-B28","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis","volume":"375","author":"Chronic Kidney Disease Prognosis C","year":"2010","journal-title":"Lancet"},{"issue":"8","key":"2024022001125568200_dgad709-B29","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1681\/ASN.2015060642","article-title":"Evaluation of short-term changes in Serum creatinine level as a meaningful End point in randomized clinical trials","volume":"27","author":"Coca","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"22","key":"2024022001125568200_dgad709-B30","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright JT","year":"2015","journal-title":"N Engl J Med"},{"issue":"14","key":"2024022001125568200_dgad709-B31","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMoa2111437","article-title":"Trial of intensive blood-pressure control in older patients with hypertension","volume":"385","author":"Zhang","year":"2021","journal-title":"N Engl J Med"},{"issue":"4","key":"2024022001125568200_dgad709-B32","doi-asserted-by":"crossref","first-page":"e028146","DOI":"10.1161\/JAHA.122.028146","article-title":"Markers of kidney tubular function deteriorate while those of kidney tubule health improve in primary aldosteronism after targeted treatments","volume":"12","author":"Wu","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"2024022001125568200_dgad709-B33","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa1515920","article-title":"Empagliflozin and progression of kidney disease in type 2 diabetes","volume":"375","author":"Wanner","year":"2016","journal-title":"N Engl J Med"},{"issue":"12","key":"2024022001125568200_dgad709-B34","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"issue":"23","key":"2024022001125568200_dgad709-B35","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","article-title":"Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients","volume":"359","author":"Jamerson","year":"2008","journal-title":"N Engl J Med"},{"issue":"1","key":"2024022001125568200_dgad709-B36","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/HYPERTENSIONAHA.118.12060","article-title":"Acute increases in Serum creatinine after starting angiotensin-converting enzyme inhibitor-based therapy and effects of its continuation on Major clinical outcomes in type 2 diabetes Mellitus","volume":"73","author":"Ohkuma","year":"2019","journal-title":"Hypertension"},{"issue":"1","key":"2024022001125568200_dgad709-B37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/j.ajkd.2018.07.015","article-title":"Effects of intensive blood pressure lowering on kidney tubule injury in CKD: a longitudinal subgroup analysis in SPRINT","volume":"73","author":"Malhotra","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"2024022001125568200_dgad709-B38","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/j.ajkd.2019.06.009","article-title":"Change in albuminuria and GFR as End points for clinical trials in early stages of CKD: a scientific workshop sponsored by the national kidney foundation in collaboration with the US food and drug administration and European medicines agency","volume":"75","author":"Levey","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"2024022001125568200_dgad709-B39","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1681\/ASN.2017010055","article-title":"Relationship of kidney injury biomarkers with long-term cardiovascular outcomes after cardiac surgery","volume":"28","author":"Parikh","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2024022001125568200_dgad709-B40","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa1105351","article-title":"Bardoxolone methyl and kidney function in CKD with type 2 diabetes","volume":"365","author":"Pergola","year":"2011","journal-title":"N Engl J Med"},{"issue":"6","key":"2024022001125568200_dgad709-B41","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2215\/CJN.05090418","article-title":"Ptolemy and copernicus revisited: the Complex interplay between the kidneys and heart failure","volume":"13","author":"Coca","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"2024022001125568200_dgad709-B42","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1590\/s1677-5538.ibju.2018.0482","article-title":"Predictors of complication after adrenalectomy","volume":"45","author":"Srougi","year":"2019","journal-title":"Int Braz J Urol"},{"issue":"6","key":"2024022001125568200_dgad709-B43","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2215\/CJN.01250119","article-title":"Quality improvement goals for acute kidney injury","volume":"14","author":"Kashani","year":"2019","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgad709\/54642009\/dgad709.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/3\/e965\/56680724\/dgad709.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/3\/e965\/56680724\/dgad709.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T20:15:39Z","timestamp":1708373739000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/109\/3\/e965\/7459149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,5]]},"references-count":43,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,12,5]]},"published-print":{"date-parts":[[2024,2,20]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgad709","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,3]]},"published":{"date-parts":[[2023,12,5]]}}}